C
Carolyn F. Pedley
Researcher at Wake Forest University
Publications - 22
Citations - 443
Carolyn F. Pedley is an academic researcher from Wake Forest University. The author has contributed to research in topics: Diabetes mellitus & Blood pressure. The author has an hindex of 10, co-authored 22 publications receiving 356 citations. Previous affiliations of Carolyn F. Pedley include Wake Forest Baptist Medical Center.
Papers
More filters
Journal ArticleDOI
The Healthy Living Partnerships to Prevent Diabetes Study: 2-Year Outcomes of a Randomized Controlled Trial
Jeffrey A. Katula,Mara Z. Vitolins,Timothy M. Morgan,Michael S. Lawlor,Caroline S. Blackwell,Scott Isom,Carolyn F. Pedley,David C. Goff +7 more
TL;DR: In this article, the authors examined the impact of a 24-month, community-based diabetes prevention program on fasting blood glucose, insulin, insulin resistance, body weight, waist circumference, and BMI in the second year of follow-up.
Journal ArticleDOI
Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.
Jerome L. Fleg,Gregory W. Evans,Karen L. Margolis,Joshua I. Barzilay,Jan Basile,J. Thomas Bigger,Jeffrey A. Cutler,Richard H. Grimm,Carolyn F. Pedley,Kevin A. Peterson,Rodica Pop-Busui,JoAnn M. Sperl-Hillen,William C. Cushman +12 more
TL;DR: In the ACCORD (Action to Control Cardiovascular Risk in Diabetes) BP trial, seated BP was measured 3×, followed by readings every minute for 3 minutes after standing as mentioned in this paper.
Journal ArticleDOI
Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT.
Stephen P. Juraschek,Addison A. Taylor,Jackson T. Wright,Gregory W. Evans,Edgar R. Miller,Timothy B Plante,William C. Cushman,Tanya R. Gure,William E. Haley,Imran Moinuddin,John Nord,Suzanne Oparil,Carolyn F. Pedley,Christianne L. Roumie,Jeff Whittle,Alan Wiggers,Ciaran Finucane,Ciaran Finucane,Rose Anne Kenny,Lawrence J. Appel,Raymond R. Townsend +20 more
TL;DR: Symptomless OH during hypertension treatment should not be viewed as a reason to down-titrate therapy even in the setting of a lower BP goal, and BP treatment goal had no effect on OH’s association with hypotension and bradycardia.
Journal ArticleDOI
The use of electronic medical records for recruitment in clinical trials: findings from the Lifestyle Intervention for Treatment of Diabetes trial
Valery S. Effoe,Valery S. Effoe,Jeffrey A. Katula,Julienne K. Kirk,Carolyn F. Pedley,Linda Y. Bollhalter,W. Mark Brown,Margaret R. Savoca,Stedman T. Jones,Janet Baek,Alain G. Bertoni +10 more
TL;DR: Future clinical studies should tailor their recruitment strategies based on the participant demographics of interest, and efficient methods such as using the EMR system and referrals should be prioritized over labor-intensive, low-yielding methodssuch as community screenings and mass mailings.
Journal ArticleDOI
Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.
Amy K. Mottl,John B. Buse,Faramarz Ismail-Beigi,Ronald J. Sigal,Carolyn F. Pedley,Vasilios Papademetriou,Debra L. Simmons,Lois A. Katz,Josyf C. Mychaleckyj,Timothy E. Craven +9 more
TL;DR: In people with type 2 diabetes at high risk for cardiovascular disease, intensive glycemic control may result in a long-term reduction in macroalbuminuria; however, intensive BP control and fenofibrates may increase the risk for adverse kidney events.